Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
about
Methotrexate for high-grade osteosarcoma in children and young adultsMethotrexate for high-grade osteosarcoma in children and young adultsOsteosarcoma: Current Treatment and a Collaborative Pathway to SuccessIndian data on bone and soft tissue sarcomas: A summary of published study resultsReview of Osteosarcoma and Current ManagementNeoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.Evaluation of the predictive value of Her-2/neu gene expression on osteosarcoma therapy in laser-microdissected paraffin-embedded tissue.Clinicopathological analysis of osteosarcoma of jaw bones.Musculoskeletal primary tumours: treatment evaluation and detection of recurrences.Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trialComparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progressionInhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy.Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma.Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective studyBenign and malignant neoplasms of the periodontium.Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial ProtocolSmall molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase familyClinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases.Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma.What are the factors that affect survival and relapse after local recurrence of osteosarcoma?Local recurrence, survival and function after total femur resection and megaprosthetic reconstruction for bone sarcomas.Current treatment of osteosarcoma.Current treatment of high grade osteosarcoma of the extremity: review.MFH of bone and osteosarcoma show similar survival and chemosensitivity.Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years.Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.Cyclin E1 is amplified and overexpressed in osteosarcoma.Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft.Management of local recurrence of pediatric osteosarcoma following limb-sparing surgeryThe significance of MGMT protein detection in evaluation of osteosarcoma necrosis rate after cisplatin chemotherapyThe relation of tumour necrosis and survival in patients with osteosarcomaDynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma.En block surgery for osteogenic sarcoma: analysis and review of ninety operative cases
P2860
Q24234472-808FD9C1-AD66-4645-BAB6-0DA5D99A011FQ24241431-2A949187-475A-4B5C-98A0-658E255A7721Q26797555-129128C9-3912-4697-B0A6-EB3D09F10706Q28066129-20442D82-23D4-42AE-9215-09C1271EC477Q28077590-637CA612-66A0-4C02-B10D-652F8E428915Q32100844-86E71A9F-42BD-43E9-BF11-96B2D75DF0D5Q33195235-1FDB9C5C-1199-411E-8F7C-70EE7F9CEF6CQ33269945-ADE4A9AD-928A-4A08-AC6C-63D4A2A98318Q33301861-5291E044-EA2A-4953-ACBC-5138F7642F59Q33393253-04656351-F7F2-43CB-B7C3-FECAAE8BCFE4Q33395803-26BB37E4-E743-496A-8FFD-DD6BACBB6ED1Q33434899-C61839E7-EFE9-40E2-9C6D-6BE0177E1B1AQ33520381-B1852E56-75F8-42EB-B711-67B89A36D188Q33557868-CCF11F23-9E1A-418D-AD54-32C495BAF83BQ33577472-A0038703-D8EE-416A-8C7E-23C1ED49DC97Q33744672-5034D761-381B-4B8A-8C1E-6325DFBC0306Q33758207-C557208C-78D3-4479-B3B0-6C4268D8D058Q33768613-D6070FD2-2A9C-4B61-A9E5-DAC9A19A1A8BQ33781004-FF98BD05-5FC0-44BC-9E51-1E362D47F5C6Q33943320-402E079D-DC51-4D47-AD34-6C5A2CD027E8Q33948137-11962678-CCD6-422C-86CA-AC3BD9A857A6Q34028842-2235B12E-3E6D-4893-8781-3000E825B37AQ34116434-F80EE870-F35F-4612-B319-98760A3ADCABQ34161337-FC8CCA08-C038-4BAC-B732-4927E39C4836Q34164389-A25C200A-9B5F-4DF8-9365-E2E91142EBE2Q34242261-E6F41048-968F-484A-8EFC-6138A1F593CCQ34307165-B5BD9CC7-CB71-4131-9D5F-71F95CC63945Q34476910-EDA6F63D-3D30-4AF8-947F-B1CFDA42AFBFQ34588488-21F42C96-F791-4219-A9B4-8F902021F095Q34627906-BFDBAEC3-5DF3-4F48-8E0C-E345EBBA815DQ34631306-303963EB-10FF-4331-AC5B-B931947E760EQ34750535-68473B89-9E6F-411A-ADAA-21CABD709DFFQ34801120-485094CC-A48F-45D0-B6B5-3A0A308EA70BQ34905407-4A7C8FDE-26F5-40B9-889D-33221E0635E8Q34970994-1D6646AA-A647-484F-A0E1-4D5E8EC70B8EQ34976539-F9A3C06D-EBE6-47CB-8570-3D60E9E2B2EDQ35184772-A85035ED-8BA8-4160-9E86-A160D2B85590Q35574435-34D82779-C2B7-407C-9C2C-2F9BC5CBBF62Q35848410-C660A4E7-3180-43E5-BEE5-80DA7D7859D3Q35876682-952D1929-2EDA-4255-910A-AEDFF3039D34
P2860
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Preoperative chemotherapy for ...... to preoperative chemotherapy.
@en
Preoperative chemotherapy for ...... to preoperative chemotherapy.
@nl
type
label
Preoperative chemotherapy for ...... to preoperative chemotherapy.
@en
Preoperative chemotherapy for ...... to preoperative chemotherapy.
@nl
prefLabel
Preoperative chemotherapy for ...... to preoperative chemotherapy.
@en
Preoperative chemotherapy for ...... to preoperative chemotherapy.
@nl
P2093
P1433
P1476
Preoperative chemotherapy for ...... to preoperative chemotherapy.
@en
P2093
Caparros B
Marcove RC
Nirenberg A
P304
P356
10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E
P407
P577
1982-03-01T00:00:00Z